Product Description
PEG-rhG-CSF for Injection ( PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection ) for the patients of non-myeloablative malignancy with the treatment of Antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia. PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection is not used for the mobilization of peripheral blood progenitor cell for hematopoietic stem cell transplantation.
Drug Name
Generic Name. PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection
English Name. PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection
PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection Description
clear liquid
PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection Indications
1. It is used for the patients of non-myeloablative malignancy with the treatment of antineoplastic, when may have clinic significance of febrile neutrophilic reduce myelosuppression, using this product to reduce the incidence rate of infection caused by febrile neutropenia.
2. This product is not used for the mobilization of peripheral blood progenitor cell for hematopoietic stem cell transplantation.
PEGylated Recombinant Human Granulocyte Colony Stimulating Factor Injection Contraindication
It is prohibited for allergic to PEG-rhG-CSF,rhG-CSF and e.coli expression of other preparations.The patients with serous liver,kidney,heart,lung dysfunction is disabled.
Specification
3 mg/ml
Packaging
1 bottle/box
Preparations
injection
